Branched-Chain Amino Acid Catabolism

A nitrogen transfer system and a signal, supplied far above physiological concentrations.

Two Steps, One Regulatory Node

StepEnzymeCompartmentReversible
BCAA + α-ketoglutarate → branched-chain keto acid + glutamateBCAT1 (cytosolic), BCAT2 (mitochondrial)BothYes
Branched-chain keto acid → acyl-CoABCKDH complex (BCKDHA/B, DBT, DLD)MitochondrialNo
BCKDH inactivationBCKDK (phosphorylation)Mitochondrial—
BCKDH activationPPM1K (phosphatase)Mitochondrial—

Important distinction. BCAT is reversible and BCKDH is not. This asymmetry means that the first step can run in either direction depending on the α-ketoglutarate and glutamate gradients, so a BCAA can donate its amino group without being catabolised for energy. Most BCAA measurements cannot distinguish transfer from catabolism.

Part 1 — The Three BCAAs Have Different Fates

BCAACarbon fateAnaplerotic or ketogenic
LeucineAcetyl-CoA and acetoacetateKetogenic; no net anaplerosis
IsoleucineAcetyl-CoA and propionyl-CoABoth; propionyl-CoA is anaplerotic
ValineSuccinyl-CoAAnaplerotic

Caveat on treating BCAAs as a class. Leucine cannot replenish TCA intermediates; valine can. A study that measures "total BCAA" consumption and concludes that the TCA cycle was replenished has conflated three different carbon fates. Reporting the three separately is the minimum for a catabolism claim.

Part 2 — The Signalling Role

Leucine activates mTORC1 through Sestrin2 binding and through the lysosomal machinery described in the signalling literature. This is a signalling role that depends on leucine concentration, not on its catabolism.

RoleConcentration dependenceReadout
mTORC1 activationSharp; sensitive around physiological leucinep-S6K1, p-4E-BP1
Nitrogen donationProportional to concentration¹⁵N transfer to glutamate and aspartate
Energy productionRequires BCKDH activity¹³C-leucine oxidation
Protein synthesis substrateProportional to demandIncorporation

Readout note. In culture, leucine is typically present at 0.4–0.8 mM, while plasma leucine is around 0.1–0.2 mM. The higher concentration means mTORC1 is often near-maximally activated at baseline, which compresses the dynamic range for a leucine experiment. A "leucine effect" measured in standard medium may be smaller than the same effect measured at a physiological concentration — or absent.

Part 3 — BCKDH Regulation

BCKDH activity is controlled by phosphorylation, and the balance between BCKDK and PPM1K sets it.

ManipulationBCKDH activityConsequence
BCKDK overexpressionLowBCAA and BCKA accumulate
PPM1K activationHighBCAA clearance increases
High protein intakeLow (in some tissues)BCAA remain elevated
Exercise or fastingTissue-dependentDifferent directions in muscle and liver

Important distinction. BCKDH regulation is tissue-specific and differs between species. Findings in mouse liver do not transfer automatically to human skeletal muscle, and the direction of the response to feeding differs between the two. A BCAA claim should name the tissue and the species.

Part 4 — Plasma BCAA and Insulin Resistance

Elevated circulating BCAAs are consistently associated with insulin resistance and predict type 2 diabetes in prospective cohorts. The causality question is separate and remains open.

InterpretationSupporting observation
BCAA elevation is a marker of impaired catabolismBCKDH activity is reduced in insulin-resistant tissue
BCAA elevation contributes to insulin resistanceBCAA infusion and BCKDK manipulation affect glucose handling in models
Both reflect a common upstream defectChanges in adipose tissue and liver metabolism precede both

Caveat on the association. A prospective association with a hazard ratio is not a mechanism, and the mediation analyses published so far are consistent with several models. In cell culture, BCAA concentrations far above plasma make it difficult to test the physiological question at all.

Part 5 — Model Requirements and Recurring Failures

RequirementWhy
Medium BCAA concentrations statedThey exceed plasma in most formulations
BCAA and BCKA measured togetherThe keto acids reveal catabolic flux
The three BCAAs reported separatelyCarbon fates differ
Tissue and species statedBCKDH regulation differs
Proliferation and mTORC1 measuredSignalling role competes with catabolism
Timepoint matched to the processTransfer is fast; catabolism is slower

Recurring failures:

  • • Total BCAA reported, hiding the three different fates.
  • • Nitrogen transfer reported as catabolism.
  • • mTORC1 effects reported as metabolic effects, or the reverse.
  • • Culture concentrations treated as physiological.
  • • BCKDH activity inferred from BCAA concentration, which is also set by supply.
  • • Mouse tissue findings transferred to human muscle.
  • • BCKA not measured, so the irreversible step is unobserved.

Part 6 — Where This Article Connects

This is the BCAA article of the amino acid cluster, and it is the second major nitrogen-transfer system after glutamine. It connects to the glutaminolysis article through α-ketoglutarate, which BCAT consumes, and to the nucleotide article through the anaplerotic contribution of valine and isoleucine. The BCAA measurement article in this cluster covers the analytical detail.

If you need BCAA and BCKA measured with the three amino acids resolved, we can scope the analysis with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

BCAA concentrations, BCAT and BCKDH expression and their regulation vary with tissue, species and nutritional state. The patterns here are conditional.

BCAA concentration does not establish catabolic flux, and a prospective association with metabolic disease does not establish causality.

Scientific interpretation and experimental design

  • • BCAT is reversible; BCKDH is not. Transfer is not catabolism.
  • • Three BCAAs, three fates. Leucine cannot anaplerose.
  • • Culture is supraphysiological. State the concentration.
  • • Measure the keto acids.
  • • Signalling and catabolism are different claims.
  • • Species and tissue matter.

Selected references for further reading

  • • Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nature Reviews Endocrinology. 2014;10:723–736.
  • • Neinast M, Murashige D, Arany Z. Branched chain amino acids. Annual Review of Physiology. 2019;81:139–164.
  • • White PJ, et al. The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metabolism. 2018;27:1281–1293.
  • • Yoon MS. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients. 2016;8:405.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: